Background
Patients with chronic kidney disease (CKD) often have complex medication regimens and are at a high-risk of drug therapy problems (DTPs). In 2016, a consensus list of renal quality indicator drug therapy problems (QI-DTPs) was developed to aid renal pharmacists in improving the quality of renal pharmaceutical care. Recent research demonstrated that renal pharmacists felt that knowledge gaps could be potential barriers but believed that implementation of these QI-DTPs could lead to better patient care. This study assessed patient preferences and priorities surrounding the type of medication information they require in order to make decisions about drug therapy and to understand if patients’ priorities align with the list of QI-DTPs and current Canadian renal pharmacy practice.

Objectives
•	To determine the type of information renal patients require to make decisions about drug therapy.
•	To determine the type of medication-related information renal patients would like to enable them to adhere to their medication regimen.  
•	To obtain patient input on a previously developed list of renal pharmacist QI-DTPs. 
•	To help inform the development of an intervention to increase the uptake of renal pharmacist QI-DTPs

Methods
The study design was prospective and qualitative research conducted utilizing semi-structured interviews with 10 patients with CKD. The results were analyzed using coding and thematic analysis.

Results
Patients want to learn about medication side effects and expected benefits. They find medical terminology and increasing volumes of paperwork to be unhelpful. Patients stated that additional information or discussion about benefits would not help optimize medication adherence. The QI-DTPs were of high priority to patients. Patients expect their medications to slow the progression of CKD and improve their health. 

Conclusions 
Themes emerged including types of useful, unhelpful and sources of information as well as barriers and enablers to adherence to medication and priorities of QI-DTPs of co-morbid conditions.

Patient perspectives on delivery of drug therapy information and renal pharmacist quality-indicator drug therapy problems